• Participants have access to resources, technology and expertise (including a staff of 14) for early, first steps in the drug discovery process
• Awarded a scope of work with all expenses paid
• Opportunity to learn from other scientists, venture investors, and pharma and biotech veterans who have led large teams to develop new medicines in industry
• An early look at projects that have initial seed investment dollars and that have been matured and de-risked by a team of skilled drug developers
• View of early-stage opportunities with an ability to specify the data needed to assess the opportunity’s value
• With Yale receiving the majority of NIH-funded research in CT, a window into innovative research in the state
PITCH received an investment of $12.5 million over four years from the Connecticut Bioscience Innovation Fund.
PITCH has funded 24 projects addressing unmet clinical needs in cancer, inflammation and infectious disease with levels of support exceeding $500,000 for projects since inception.